HOME >> BIOLOGY >> NEWS
Identifying genes that contribute to a low level of response to alcohol

  • A low level of response (LR) to alcohol is predictive of future risk of alcoholism.
  • Previous research has found that a low LR has a heritability as high as 60 percent, which implies a genetic link.
  • A review of previous research has identified several categories of genes of potential interest.

Alcoholism is a complex, genetically influenced disorder. Multiple phenotypes measurable and/or observable traits or behavior contribute to the risk of developing alcoholism, particularly disinhibition, alcohol metabolizing patterns, and a low level of response (LR) to alcohol. A low LR to alcohol seems to be particularly relevant, with data indicating that LR relates to risk status, predicts future alcoholism, and has a heritability as high as 60 percent. A review in the October issue of Alcoholism: Clinical & Experimental Research examines previous research, seeking to identify those genes that may contribute to a low LR to alcohol.

"Prospective studies have shown that a low response to alcohol absolutely does increase your risk for future alcohol-related problems, at least in part by changing your expectations of what it is that you expect during drinking," said Marc A. Schuckit, director of the Alcohol Research Center, Veterans Affairs San Diego Healthcare System, professor of psychiatry at the University of California, San Diego, and first author of the study.

"However," Schuckit added, "the key is that people drink especially early in their careers for effect, which often means intoxication. An individual who experiences not much of an effect from alcohol will still feel effects like anybody else, but they'll just require more to do it, and this will probably impact their expectations of what alcohol is going to do for them."

"Different people have a different initial response to alcohol, also known as level of sensitivity," said David Goldman, chief of the Laboratory of Neurogenetics at the
'"/>


14-Oct-2004


Page: 1 2 3

Related biology news :

1. Identifying the mechanism behind a genetic susceptibility to type 2 diabetes
2. Identifying the nuclear in nuclear medicine as high benefit
3. Identifying Piwis partners
4. Contagious obesity? Identifying the human adenoviruses that may make us fat
5. Identifying the signatures of protons in water
6. Identifying blood stem cells is a SLAM dunk
7. Identifying the path to infection
8. Interaction of just 2 genes governs coloration patterns in mice
9. Gene regulation, not just genes, is what sets humans apart
10. Study finds gender differences in renal and other genes contributing to blood pressure
11. New databases put wings on search for bipolar risk genes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Identifying genes that contribute low level response alcohol

(Date:12/10/2014)... RALEIGH, N.C. , Dec. 9, 2014  Valencell, ... announced it is seeing a staggering demand from its ... demand, the Company revealed, is not solely coming from ... industries as well. "A wearable is only ... a result, accuracy is the ultimate driver in long-term ...
(Date:12/10/2014)... Dec. 9, 2014 CIE San Diego has ... provides the connective tissue that enhances care coordination among ... easily share client-level information; earned a second $1 million ... organizations serving seniors aging in community and; will be ... December 11 th 4-6p. CIE San ...
(Date:12/10/2014)... 2014     ...   Jifflenow, a leading ... for business-to-business (B2B) events, today announced a partnership ... near-field communication (NFC), Bluetooth low energy (BLE), and ... , Jifflenow will integrate its meeting ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
(Date:12/19/2014)... 18, 2014 iLab Solutions, the global ... of Siri Bryant as the new Director of Institutional ... Core Implementations. These two new leadership positions were created ... by ensuring that iLab continues to meet the needs ... four years, iLab has been deployed at over 450 ...
(Date:12/19/2014)... BURLINGTON, Mass. , Dec. 18, 2014  Decision ... dental biomaterial market will grow moderately through ... implant procedures and growing awareness of dental biomaterials all ... underdeveloped markets such as China ... incomes will bring dental procedures within reach for a ...
(Date:12/17/2014)... December 16, 2014 The Activated ... 2013, which is why IBISWorld updated its original industry ... to benefit from an intensified focus on environmental policy. ... new emission standards for power plants and a range ... to IBISWorld Industry Analyst Sarah Kahn, “a range of ...
(Date:12/17/2014)... 17, 2014 Ipsen Biopharmaceuticals, Inc., ... ADR: IPSEY), today announced that Somatuline® ... Somatuline®) was approved by the U.S. Food and ... neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, ... disease to improve progression-free survival (PFS). , “The ...
Breaking Biology Technology:iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
Cached News: